pharmaceutical drugs

671 projects

HEIndividual fellowship2027–2029France

JAK2-TB · Human JAK2 genotypes underlying tuberculosis

3 partners

HEDoctoral network2027–2031United Kingdom

RADICALLY · Enantioselective Catalysis for Radical Transformations

13 partners · 6 countries

HEIndividual fellowship2027–2029Ireland

AURa · Antibacterial and pro-Angiogenic electroconductive scaffold for functional woUnd Regen-eration with neurogenic cues

HEIndividual fellowship2027–2029Sweden

SHINE-Vax · Smart Hydrogel Microneedle Patches for mRNA Nanoparticle Vaccination

HEIndividual fellowship2027–2029Finland

UNFENCED · Unravelling Nanoplastics: The Fate of Emerging Contaminants and Nanoplastics Concomitance in Environmental Dynamics

HEIndividual fellowship2027–2030Germany

EvoComb · Evolution under sequential antibiotic combinations: integrating clinical data into models and experiments to tackle resistance

3 partners · 3 countries

HEIndividual fellowship2027–2028Denmark

IRGOP · Immunometabolic Reprogramming via a Gut-derived Organoid Platform

HEIndividual fellowship2027–2028Austria

GlycoIMPACT · Glycoengineering for Immune Modulation in Precision Anti-Cancer Therapies

2 partners · 2 countries

HEIndividual fellowship2027–2029Spain

CLUSTERS · Controlling Polymorphism Using Optimal Electric Fields

HEStaff exchange2027–2030Norway

BIOVIRAL · Biofuel-based Innovation for the Optimization of VIRAL inhibition through alcohol-ligand modeling

3 partners · 3 countries

HEIndividual fellowship2027–2029Italy

MCG-QUAD · Machine Learning-Enhanced Coarse-Grained Modelling of Telomeric G-Quadruplex Multimers: A Multiscale Study

HEIndividual fellowship2026–2029France

MIND · Multiscale Investigation of the Neural and electrochemical correlates of temporal Distortions

2 partners · 2 countries

HEIndividual fellowship2026–2028Spain

VaccinNate · From adjuvants-based vaccines for inflammatory diseases to refined vaccine adjuvants

HEIndividual fellowship2026–2028United Kingdom

SYNTH HORSE · Trojan‑Horse Siderophore–Teixobactin Conjugates to Defeat Gram‑Negative Superbugs

2 partners · 2 countries

HEIndividual fellowship2026–2028United Kingdom

M2-CPID · Multiscale Modelling of Microfluidic Cell Mechanoporation for Intracellular Gene Delivery

HEIndividual fellowship2026–2028Spain

semiQ2 · Semiquantification based on ionization efficiency for human exposure leveraging ion mobility separation

HEIndividual fellowship2026–2028France

PRISM · Beyond the binary: ProgRammIng of Sexual immune identity from thyMus to tissues

HEIndividual fellowship2026–2028Germany

HALOGEN · HALOgenase-driven high-throughput experimentation and GENome mining

HEIndividual fellowship2026–2028Spain

CESAm-HAT · Carbonyl-catalyzed EnantioSelective synthesis of primary Amines via Hydrogen-Atom Transfer activation

HEIndividual fellowship2026–2028France

PG-BIR · Elucidating the Role of Peptidoglycan Fragments in β-Lactam-Induced Host Immune Responses

HEIndividual fellowship2026–2028United Kingdom

AtropEnzymes · Engineering new enzymatic platforms for atroposelective C–N bond formation

2 partners · 2 countries

HEIndividual fellowship2026–2028United Kingdom

OLIGNA · Orthogonal Ligase Enzymes for Assembly of Modified Nucleic Acids

HEIndividual fellowship2026–2028Ireland

FluorNano · Fluorinated polymer nanoparticles for mRNA-based cancer therapy

2 partners · 2 countries

HEIndividual fellowship2026–2028France

BRGN · Boron Radical Route to Green Nitrogen: Mechanistic Elucidation and Closing the Synthetic Cycle